Literature DB >> 17627013

Body mass index, physical activity, and risk of multiple myeloma.

Brenda M Birmann1, Edward Giovannucci, Bernard Rosner, Kenneth C Anderson, Graham A Colditz.   

Abstract

Several studies have reported a positive relation of baseline body mass index (BMI) with multiple myeloma, but data on other correlates of energy balance are limited. We undertook the present analyses to further examine the role of energy balance in multiple myeloma etiology in two large prospective cohorts with biennially updated exposure data. We followed members of the Nurses' Health Study and Health Professionals Follow-up Study cohorts from baseline until multiple myeloma diagnosis, death, or 2002. Adult height and current weight were reported at enrollment, and weight every 2 years thereafter. Physical activity was queried at baseline and updated every 2 to 4 years. We computed age-adjusted relative risks (RR) of multiple myeloma for categories of BMI and physical activity using Cox proportional hazards regression. We conducted analyses on each cohort separately and on both cohorts combined. We confirmed 215 incident cases of multiple myeloma in the combined cohort of 136,623 individuals (>2.1 million person-years at risk). BMI was positively associated with multiple myeloma in all analyses. The association was strongest in men with a BMI of >or=30 kg/m2 (versus a BMI of <22.0 kg/m2; RR, 2.4; 95% confidence interval, 1.0-6.0) and modest in overweight (BMI, 25-29.9 kg/m2) and obese (BMI, >or=30 kg/m2) women [versus BMI of <22.0 kg/m2; RR (95% confidence interval), 1.6 (1.0-2.7) and 1.2 (0.7-2.2), respectively]. Physical activity was not significantly related to multiple myeloma risk, although an inverse association was suggested in women. In conclusion, obesity seems to have an etiologic role in multiple myeloma, but the role of other correlates of energy balance remains uncertain.

Entities:  

Mesh:

Year:  2007        PMID: 17627013      PMCID: PMC3860750          DOI: 10.1158/1055-9965.EPI-07-0143

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  36 in total

1.  Insulin-like growth factor I is a dual effector of multiple myeloma cell growth.

Authors:  N L Ge; S Rudikoff
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.

Authors:  Wendy Cozen; Mulugeta Gebregziabher; David V Conti; David J Van Den Berg; Gerhard A Coetzee; Sophia S Wang; Nathaniel Rothman; Leslie Bernstein; Patricia Hartge; Ann Morhbacher; Simon G Coetzee; Muhammad T Salam; Wei Wang; John Zadnick; Sue A Ingles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

3.  Anthropometric characteristics and risk of multiple myeloma.

Authors:  Cindy K Blair; James R Cerhan; Aaron R Folsom; Julie A Ross
Journal:  Epidemiology       Date:  2005-09       Impact factor: 4.822

Review 4.  Epidemiology and outcomes research for MGUS, myeloma and amyloidosis.

Authors:  Bhawna Sirohi; Ray Powles
Journal:  Eur J Cancer       Date:  2006-07-25       Impact factor: 9.162

5.  Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States.

Authors:  L M Brown; G Gridley; L M Pottern; D Baris; C A Swanso; D T Silverman; R B Hayes; R S Greenberg; G M Swanson; J B Schoenberg; A G Schwartz; J F Fraumeni
Journal:  Cancer Causes Control       Date:  2001-02       Impact factor: 2.506

Review 6.  The Nurses' Health Study: lifestyle and health among women.

Authors:  Graham A Colditz; Susan E Hankinson
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

7.  Physical activity and mortality: a prospective study among women.

Authors:  B Rockhill; W C Willett; J E Manson; M F Leitzmann; M J Stampfer; D J Hunter; G A Colditz
Journal:  Am J Public Health       Date:  2001-04       Impact factor: 9.308

8.  Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival.

Authors:  Niels Frost Andersen; Therese Standal; Johan Lanng Nielsen; Lene Heickendorff; Magne Borset; Flemming Brandt Sørensen; Niels Abildgaard
Journal:  Br J Haematol       Date:  2005-01       Impact factor: 6.998

9.  Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States).

Authors:  Mulugeta Gebregziabher; Leslie Bernstein; Yaping Wang; Wendy Cozen
Journal:  Cancer Causes Control       Date:  2006-09       Impact factor: 2.506

Review 10.  Obesity and the role of adipose tissue in inflammation and metabolism.

Authors:  Andrew S Greenberg; Martin S Obin
Journal:  Am J Clin Nutr       Date:  2006-02       Impact factor: 7.045

View more
  23 in total

1.  Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.

Authors:  Lauren R Teras; Cari M Kitahara; Brenda M Birmann; Patricia A Hartge; Sophia S Wang; Kim Robien; Alpa V Patel; Hans-Olov Adami; Elisabete Weiderpass; Graham G Giles; Pramil N Singh; Michael Alavanja; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Graham A Colditz; Gary E Fraser; Susan M Gapstur; J Michael Gaziano; Edward Giovannucci; Jonathan N Hofmann; Martha S Linet; Gila Neta; Yikyung Park; Ulrike Peters; Philip S Rosenberg; Catherine Schairer; Howard D Sesso; Meir J Stampfer; Kala Visvanathan; Emily White; Alicja Wolk; Anne Zeleniuch-Jacquotte; Amy Berrington de González; Mark P Purdue
Journal:  Br J Haematol       Date:  2014-05-23       Impact factor: 6.998

2.  Search for multiple myeloma risk factors using Mendelian randomization.

Authors:  Molly Went; Alex J Cornish; Philip J Law; Ben Kinnersley; Mark van Duin; Niels Weinhold; Asta Försti; Markus Hansson; Pieter Sonneveld; Hartmut Goldschmidt; Gareth J Morgan; Kari Hemminki; Björn Nilsson; Martin Kaiser; Richard S Houlston
Journal:  Blood Adv       Date:  2020-05-26

3.  Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study.

Authors:  Jonathan N Hofmann; Steven C Moore; Unhee Lim; Yikyung Park; Dalsu Baris; Albert R Hollenbeck; Charles E Matthews; Todd M Gibson; Patricia Hartge; Mark P Purdue
Journal:  Am J Epidemiol       Date:  2013-03-29       Impact factor: 4.897

4.  Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies.

Authors:  Philipp M Altrock; Jeremy Ferlic; Tobias Galla; Michael H Tomasson; Franziska Michor
Journal:  JCO Clin Cancer Inform       Date:  2018-12

Review 5.  Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.

Authors:  Arun Balakumaran; Pamela Gehron Robey; Neal Fedarko; Ola Landgren
Journal:  Expert Rev Mol Diagn       Date:  2010-05       Impact factor: 5.225

6.  Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.

Authors:  Jessica A Fowler; Seint T Lwin; Matthew T Drake; James R Edwards; Robert A Kyle; Gregory R Mundy; Claire M Edwards
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

7.  Regular recreational physical activity and risk of hematologic malignancies: results from the prospective VITamins And lifestyle (VITAL) study.

Authors:  R B Walter; S A Buckley; E White
Journal:  Ann Oncol       Date:  2012-12-17       Impact factor: 32.976

8.  Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.

Authors:  Brenda M Birmann; Marian L Neuhouser; Bernard Rosner; Demetrius Albanes; Julie E Buring; Graham G Giles; Qing Lan; I-Min Lee; Mark P Purdue; Nathaniel Rothman; Gianluca Severi; Jian-Min Yuan; Kenneth C Anderson; Michael Pollak; Nader Rifai; Patricia Hartge; Ola Landgren; Lawrence Lessin; Jarmo Virtamo; Robert B Wallace; JoAnn E Manson; Graham A Colditz
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

Review 9.  Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic.

Authors:  Brenda M Birmann; Mollie E Barnard; Kimberly A Bertrand; Ying Bao; Marta Crous-Bou; Brian M Wolpin; Immaculata De Vivo; Shelley S Tworoger
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

Review 10.  Bone marrow microenvironment and the identification of new targets for myeloma therapy.

Authors:  K Podar; D Chauhan; K C Anderson
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.